Hydralazine Hydrochloride



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 28.9%
Drug Use For Unknown Indication 18.4%
Product Used For Unknown Indication 18.4%
Cardiac Disorder 7.9%
Aplastic Anaemia 5.3%
Atrial Fibrillation 5.3%
Portal Hypertension 5.3%
Renal Cell Carcinoma 5.3%
Blood Glucose Increased 2.6%
Hypertensive Crisis 2.6%
Maternal Exposure During Pregnancy 14.3%
Premature Labour 11.9%
Foetal Exposure During Pregnancy 7.1%
Lupus-like Syndrome 7.1%
Medication Error 7.1%
Blood Pressure Inadequately Controlled 4.8%
Completed Suicide 4.8%
Low Birth Weight Baby 4.8%
Nausea 4.8%
Premature Baby 4.8%
Premature Delivery 4.8%
Tremor 4.8%
Acute Febrile Neutrophilic Dermatosis 2.4%
Angioedema 2.4%
Drug Hypersensitivity 2.4%
Flushing 2.4%
Interstitial Lung Disease 2.4%
Lupus Pneumonitis 2.4%
Muscle Spasms 2.4%
Normal Newborn 2.4%
Secondary
Hypertension 21.2%
Maternal Exposure Timing Unspecified 20.3%
Type 2 Diabetes Mellitus 20.3%
Product Used For Unknown Indication 15.3%
Aplastic Anaemia 5.1%
Cardiac Failure 3.4%
Essential Hypertension 2.5%
Lupus Nephritis 1.7%
Renal Cell Carcinoma 1.7%
Systemic Lupus Erythematosus 1.7%
Angina Pectoris 0.8%
Anxiety Disorder 0.8%
Bipolar Disorder 0.8%
Constipation 0.8%
Gout 0.8%
Haemolytic Uraemic Syndrome 0.8%
Lung Adenocarcinoma 0.8%
Oesophageal Disorder 0.8%
Renal Failure Acute 15.0%
Maternal Exposure During Pregnancy 12.5%
Medication Error 7.5%
Renal Aplasia 7.5%
Foetal Exposure During Pregnancy 5.0%
Neonatal Respiratory Distress Syndrome 5.0%
Pain 5.0%
Premature Baby 5.0%
Productive Cough 5.0%
Shock 5.0%
Syncope 5.0%
Abscess 2.5%
Anxiety 2.5%
Blood Pressure Systolic Increased 2.5%
Completed Suicide 2.5%
Drug Hypersensitivity 2.5%
Granulomatous Liver Disease 2.5%
Libido Decreased 2.5%
Low Birth Weight Baby 2.5%
Renal Hypoplasia 2.5%
Concomitant
Product Used For Unknown Indication 39.9%
Drug Use For Unknown Indication 20.2%
Hypertension 11.9%
Prophylaxis 3.6%
Renal Failure Chronic 3.1%
Cardiac Failure 2.8%
Pain 2.6%
Renal Transplant 2.3%
Diabetes Mellitus 2.0%
Atrial Fibrillation 1.7%
Cerebrovascular Accident 1.6%
Dialysis 1.2%
Hepatitis C 1.2%
Anaemia 0.9%
Gastrooesophageal Reflux Disease 0.9%
Haemodialysis 0.9%
Hepatic Neoplasm Malignant 0.9%
Diuretic Therapy 0.8%
Systemic Lupus Erythematosus 0.8%
Type 2 Diabetes Mellitus 0.8%
Vomiting 16.5%
Therapeutic Response Decreased 12.2%
Premature Baby 5.2%
Renal Failure Acute 5.2%
Unresponsive To Stimuli 5.2%
Ischaemic Stroke 4.3%
Pregnancy 4.3%
Pyelonephritis 4.3%
Pyrexia 4.3%
Syncope 4.3%
Cerebral Ischaemia 3.5%
Chest Pain 3.5%
Hypertension 3.5%
Hypoglycaemia 3.5%
Parvovirus B19 Serology Positive 3.5%
Pneumonia 3.5%
Rash 3.5%
Urinary Tract Infection 3.5%
Weight Decreased 3.5%
Cardiac Failure Congestive 2.6%